Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000074987 | SCV000108203 | pathogenic | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | Coding sequence variation resulting in a stop codon |
Ambry Genetics | RCV002326786 | SCV002631712 | pathogenic | Hereditary cancer-predisposing syndrome | 2021-05-28 | criteria provided, single submitter | clinical testing | The p.W142* pathogenic mutation (also known as c.426G>A), located in coding exon 2 of the MSH6 gene, results from a G to A substitution at nucleotide position 426. This changes the amino acid from a tryptophan to a stop codon within coding exon 2. This mutation was identified in the germline of an individual with MSI-H colorectal cancer that also showed loss of MSH6 protein expression and whose family met Amsterdam criteria (Plaschke J et al. Hum. Mutat., 2004 Mar;23:285; Steinke V et al. Eur. J. Hum. Genet., 2008 May;16:587-92). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Ce |
RCV003311675 | SCV004011159 | pathogenic | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | MSH6: PVS1, PM2, PS4:Supporting |
Myriad Genetics, |
RCV003450987 | SCV004185684 | pathogenic | Lynch syndrome 5 | 2023-08-10 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. |
Baylor Genetics | RCV003460698 | SCV004197732 | pathogenic | Endometrial carcinoma | 2023-09-13 | criteria provided, single submitter | clinical testing | |
Pathway Genomics | RCV000144625 | SCV000189952 | pathogenic | Lynch syndrome 1 | 2014-07-24 | no assertion criteria provided | clinical testing |